ClinicalTrials.Veeva

Menu

Comparison of Three Different Myofascial Trigger Point Treatments in Chronic Non-Specific Neck Pain

B

Biruni University

Status

Invitation-only

Conditions

Chronic Non-specific Neck Pain

Treatments

Other: Strain-Counter Strain
Other: Conventional Therapy
Other: Ischemic Compression Group
Other: Integrated Neuromuscular Inhibition Technique (INIT)

Study type

Interventional

Funder types

Other

Identifiers

NCT06814808
BiruniUni.

Details and patient eligibility

About

The aim of this study was to compare the efficacy of ischaemic compression (IC), positional relaxation (Strain Counterstrain [SCS]), and integrated neuromuscular inhibition technique (INIT) applications on pain intensity, pressure pain threshold, range of motion, joint position sense, disability, kinesiophobia, quality of life and patient satisfaction in addition to conventional treatment for chronic non-specific neck pain.

It is planned to include 51 patients in the study. The included patients will be divided into 3 groups: Group 1 (HR Group), Group 2 (SCS Group) and Group 3 (INIT Group). All three groups will receive a conventional physiotherapy programme 5 times a week for 4 weeks and the same exercise programme 3 days a week for 4 weeks.

Full description

Chronic neck pain is one of the most common musculoskeletal problems in the general population and is the second most common type of pain after low back pain worldwide. Electrophysiological agents, therapeutic exercise and trigger point therapy techniques are frequently used in chronic non-specific neck pain. There is insufficient evidence in the current literature regarding which trigger point therapy technique is more effective. The aim of this study was to compare the efficacy of ischaemic compression (IC), positional relaxation (Strain Counterstrain [SCS]), and integrated neuromuscular inhibition technique (INIT) on pain intensity, pressure pain threshold, range of motion, joint position sense, disability, kinesiophobia, quality of life and patient satisfaction in addition to conventional treatment for chronic non-specific neck pain. The study was planned to include 51 patients between the ages of 18-65 years who applied to Gebze Medicalpark Hospital and met the inclusion criteria. The included patients will be randomised and divided into 3 groups: Group 1 (HR Group), Group 2 (SCS Group) and Group 3 (INIT Group). All three groups will receive a conventional physiotherapy programme (TENS, therapeutic ultrasound, hot pack) 5 times a week for 4 weeks and the same exercise programme 3 days a week for 4 weeks. In addition to conventional treatment, Group 1 will receive HR for upper trapezius, levator scapulae, splenius capitus and lower trapezius muscles, Group 2 will receive SCS for upper trapezius, levator scapulae, splenius capitus and lower trapezius muscles and Group 3 will receive INIT for upper trapezius, levator scapulae, splenius capitus and lower trapezius muscles 3 sessions per week for 4 weeks (12 sessions in total). As evaluation criteria, visual analogue scale will be used to evaluate the intensity of pain felt at rest, activity and at night, and algometer will be used to objectively measure pain threshold and tolerance. Cervical range of motion and joint position sense will be assessed using CROM III-Cervical Range of Motion device. Disability level will be assessed using the Neck Disability Scale, fear of movement using the Tampa Kinesiophobia Scale, quality of life using the Short Form-12, and Global Change Scale to assess patient satisfaction. Assessments will be made before starting the treatment programme and after the completion of the 4-week treatment programme.

Enrollment

51 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • The patient is between 18 and 65 years of age,
  • The patient presents to the outpatient clinic with a complaint of neck pain that has been persisting for at least 3 months,
  • Pain intensity higher than 3.5/10 cm according to the Visual Analogue Scale,
  • Active trigger point in at least one of the upper trapezius, levator scapulae, splenius capitus, lower trapezius muscles that may cause neck pain,
  • Neck Disability Index total score higher than 15,
  • Having the ability to read and write in Turkish was determined as the inclusion criteria.

Exclusion criteria

  • Has had a neck, spine or shoulder injury within the last 6 months,
  • The patient has neck pain caused by inflammatory, hormonal, neurological disorders or after trauma,
  • Positive radicular findings compatible with nerve root compression, history of spinal fracture, spinal tumours and related malignancies, congenital spinal anomalies,
  • History of neck, upper thoracic spine and shoulder surgery,
  • Scoliosis surgery or a health problem that causes limitation in spinal mobility,
  • Diagnosed with any malignant condition, systemic, neurological or rheumatological disease,
  • Having a skin disease or hearing-vision problem that may affect the assessment process,
  • Uncontrolled hypertension, uncontrolled diabetes mellitus, meniere's disease and vertigo,
  • Physiotherapy sessions for neck pain in the last month,
  • Pregnancy,
  • Use of any analgesic or psychotropic agent was determined as exclusion criteria.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

51 participants in 3 patient groups

Ischaemic Compression Group
Active Comparator group
Description:
Ischaemic compression Manual therapy
Treatment:
Other: Ischemic Compression Group
Other: Conventional Therapy
Strain Counterstrain Group
Experimental group
Description:
Strain Counterstrain Manual therapy
Treatment:
Other: Conventional Therapy
Other: Strain-Counter Strain
Integrated Neuromuscular Inhibition Technique Group
Experimental group
Description:
Integrated Neuromuscular Inhibition Technique Manual therapy
Treatment:
Other: Integrated Neuromuscular Inhibition Technique (INIT)
Other: Conventional Therapy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems